Key Takeaways Updated COVID-19 vaccines have been effective against new coronavirus variantsThe vaccines lowered risk of ...

RFK Jr. turned the CDC's vaccine committee into an anti-vaccine panel, but it still heard evidence that his campaign against ...

U.S. Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel said during its first meeting on ...

Writing in JAMA, four former governmental officials warn that the Trump administration’s involvement in delaying the approval ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

On day one of the highly anticipated first meeting of the CDC's newly formed vaccine advisory committee, members debated the ...

The reconstituted C.D.C. panel will revisit the standard vaccination schedule. The former head of an anti-vaccine group is ...

U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

The vaccine is expected to be available for eligible patients for the 2025-2026 season, alongside Spikevax ® (COVID-19 Vaccine, mRNA). References: Moderna receives US FDA approval for COVID-19 ...

Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.